Interestingly, IRSp53 has been found to be a Drf1 bindantibodies [4] to confirm loss of protein expression (Figure 1C) . We found that both in vitro-derived homozygous ing partner as well [28] .
In this study of the cellular effects of Drf1 gene knockDrf1 Ϫ/Ϫ cell lines 2B1 and 2D6 did not express Drf1 protein. All three heterozygous Drf1 ϩ/Ϫ cell lines had out, we found that, in comparison to Drf1ϩ/ϩ and one Drf1ϩ/Ϫ cell line, several Drf1-deficient cell lines had diminished Drf1 protein levels. These results confirmed that we had correctly targeted the Drf1 gene. However, elevated Drf3 levels. Not surprisingly, these cell lines not only had increased actin stress fibers, reflecting when we compared these cells to wild-type Drf1 ϩ/ϩ cells (CJ7) or NIH 3T3 cells, we found altered levels of Drf3 utilization as a RhoA effector, but also contained increased cortical F-actin and filopodia. These results p134 Drf3. In both Drf1 null cell lines and one of the ϩ/Ϫ lines (2E5), we found increased expression of Drf3, led us to examine whether Drf3 was actually an effector for Cdc42, which we previously demonstrated could presumably due to cellular compensation for Drf1 loss. We then examined if the actin cytoskeleton was albind in vitro to activated Cdc42 in yeast two-hybrid and in vitro "pull-down" experiments [ with low Drf1 levels and elevated Drf3, were highly motile gene, via homologous recombination. The targeting and had multiple filopodia, microspikes, or lamella in construct was electroporated into mouse embryonic comparison to Drf1 ϩ/ϩ cells. These results led us to stem (ES) cells that were then selected for transformasuspect that Drf1 deficiency, Drf3 overexpression, or tion and expression of the neomycin-resistance gene by both events were leading to the altered cytoskeleton in G418 antibiotic selection. Selected clones were injected our cells. We then examined Drf3 localization in our into blastocysts and were implanted into pseudopregcells to determine if it was associated with these active nant female mice to generate Drf1 ϩ/Ϫ embryos and structures. then eventually homozygous Drf1 Ϫ/Ϫ mice. The results Endogenous Drf3 was monitored in fixed 2D6 cells of these experiments will be described elsewhere (J.P., by indirect immunofluorescence to determine if it was P.J.S., and A.S.A., unpublished data). associated with the filopodia or other structures. As To study the requirement for Drf1 in cytoskeletal reshown in Figure 2E , Drf3 (green) was found along radial modeling, Drf1 ϩ/Ϫ cells were selected for loss of the arrays that corresponded with stable microtubules (data second Drf1 allele by high G418 selection as described not shown). The colocalization of Drf3 on microtubules in the Experimental Procedures. G418-resistant colowas consistent with previous findings with Drf3-EGFP nies were isolated and assayed for loss of the second fusion proteins [15] . Drf3 was also found in distinct Drf1 allele by both Southern blotting and PCR-based puncta of varying sizes along the cell periphery indicated screening (data not shown). These cells were then used by arrowheads. When we visualized F-actin, it was clear to produce cells from embryoid bodies (EBs). that many of the puncta were at the edges of growing Drf1 ϩ/ϩ, ϩ/Ϫ, and Ϫ/Ϫ ES cells were plated onto Petri lamella (bottom row) or at the center of small stellate dishes and maintained in in vitro differentiation medium F-actin arrays (top row). Figure 1B In all cases, a substantial ECFP-Cdc42-V12 signal was injection approach to interfere with Drf function, a method previously used to study Drf1 in NIH 3T3 cells also located in the nucleus and at the MTOC as shown in Figure 4E, (see insets 1, 2, and 4) ; the MTOC was
[4]. We used 2D6 Drf1-knockout cells that were microin- 
